Queueing technique for Ebola Virus Disease transmission and control analysis by Dike, Chinyere Ogochukwu, Zainuddin, Zaitul Marlizawati, Dike, Ikeme John

“…Objective: The outbreak of Ebola Virus Disease (EVD) in different countries, especially the West African nations has been ravaging human lives and the economy. …”

Implication of uncertainty and sensitivity analysis of Ebola virus disease transmission by Datilo, P. M., Ismail, Z.

Socio - economic consequences of Ebola virus outbreaks in West Africa by Mashi, AminaLawal, Yusof, Rohana @ Norliza

“…The paper recommends (amongst others) a holistic approach in tackling the menace of Ebola virus as one of the most deadly disease known to human society in recent history.…”
Get full text

Socio-economic consequences of Ebola virus outbreaks in West Africa by Mashi, AminaLawal, Yusof, Rohana

“…The paper recommends (amongst others) a holistic approach in tackling the menace of Ebola virus as one of the most deadly disease known to human society in recent history.…”
Get full text

Estimating Ebola Treatment Needs, United States by Gabriel Rainisch, Jason Asher, Dylan George, Matt Clay, Theresa L. Smith, Christine Kosmos, Manjunath B. Shankar, Michael L. Washington, Manoj Gambhir, Charisma Atkins, Richard Hatchett, Tim Lant, Martin I. Meltzer

Subjects: “…Ebola virus infection…”
Get full text

What Is the Impact of the Ebola Virus Disease Outbreak on Cancer Management in Guinea? by Bangaly Traore, Mamady Kourouma, Malick Bah, Mamady Keita

“…PURPOSE To assess the impact of the Ebola virus disease outbreak (EVDO) on cancer management at the surgical oncology unit of Donka National Hospital. …”
Get full text

Proportion of Deaths and Clinical Features in Bundibugyo Ebola Virus Infection, Uganda by Adam MacNeil, Eileen C. Farnon, Joseph F. Wamala, Sam Okware, Deborah L. Cannon, Zachary Reed, Jonathan S. Towner, Jordan W. Tappero, Julius Lutwama, Robert Downing, Stuart T. Nichol, Thomas G. Ksiazek, Pierre E. Rollin

“…The first known Ebola hemorrhagic fever (EHF) outbreak caused by Bundibugyo Ebola virus occurred in Bundibugyo District, Uganda, in 2007. …”
Get full text

Initiating a watch list for Ebola virus antibody escape mutations by Craig R. Miller, Erin L. Johnson, Aran Z. Burke, Kyle P. Martin, Tanya A. Miura, Holly A. Wichman, Celeste J. Brown, F. Marty Ytreberg

“…The 2014 Ebola virus (EBOV) outbreak in West Africa is the largest in recorded history and resulted in over 11,000 deaths. …”
Get full text

Ramachandran plots of envelope glycoprotein GP2 from Ebola virus by Sora Yasri, Viroj Wiwanitkit

Get full text

Prediction and identification of mouse cytotoxic T lymphocyte epitopes in Ebola virus glycoproteins by Wu Shipo, Yu Ting, Song Xiaohong, Yi Shaoqiong, Hou Lihua, Chen Wei

Subjects: “…Ebola virus…”
Get full text

The end of the Ebola virus disease epidemic: has the work just begun? by Mark J Siedner, John D Kraemer

Get full text

Shelf-Life of Chlorine Solutions Recommended in Ebola Virus Disease Response. by Qais Iqbal, Maya Lubeck-Schricker, Emma Wells, Marlene K Wolfe, Daniele Lantagne

“…In Ebola Virus Disease (EVD) outbreaks, it is widely recommended to wash living things (handwashing) with 0.05% (500 mg/L) chlorine solution and non-living things (surfaces, personal protective equipment, dead bodies) with 0.5% (5,000 mg/L) chlorine solution. …”
Get full text

Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys. by Wendelien B Oswald, Thomas W Geisbert, Kelly J Davis, Joan B Geisbert, Nancy J Sullivan, Peter B Jahrling, Paul W H I Parren, Dennis R Burton

“…In this study, we have investigated the ability of the neutralizing human monoclonal antibody, KZ52, to protect against Ebola virus in rhesus macaques. This antibody was previously shown to fully protect guinea pigs from infection. …”
Get full text

Mechanisms of immunity in post-exposure vaccination against Ebola virus infection. by Steven B Bradfute, Scott M Anthony, Kelly S Stuthman, Natarajan Ayithan, Prafullakumar Tailor, Carl I Shaia, Mike Bray, Keiko Ozato, Sina Bavari

“…In this work, we report that VLPs protect Ebola virus-infected mice when given 24 hours post-infection. …”
Get full text

Unusual Ebola Virus Chain of Transmission, Conakry, Guinea, 2014–2015 by Mory Keita, Sophie Duraffour, Nicholas J. Loman, Andrew Rambaut, Boubacar Diallo, Nfaly Magassouba, Miles W. Carroll, Joshua Quick, Amadou Sall, Judith R. Glynn, Pierre Formenty, Lorenzo Subissi, Ousmane Faye

Subjects: Get full text

The Baboon (Papio spp.) as a Model of Human Ebola Virus Infection by Gary L.White, Laura Bollinger, Donna L. Perry

Subjects: Get full text

Natural History of Aerosol-Induced Ebola Virus Disease in Rhesus Macaques by Isaac Downs, Joshua C. Johnson, Franco Rossi, David Dyer, David L. Saunders, Nancy A. Twenhafel, Heather L. Esham, William D. Pratt, John Trefry, Elizabeth Zumbrun, Paul R. Facemire, Sara C. Johnston, Erin L. Tompkins, Nathan K. Jansen, Anna Honko, Anthony P. Cardile

“…Ebola virus disease (EVD) is a serious global health concern because case fatality rates are approximately 50% due to recent widespread outbreaks in Africa. …”
Get full text

A humanitarian response to the West African Ebola virus disease outbreak by Linda M. Mobula, Jolene H. Nakao, Sonia Walia, Justin Pendarvis, Peter Morris, David Townes

Subjects: “…Ebola virus disease…”
Get full text

Generation and Characterization of a Mouse-Adapted Makona Variant of Ebola Virus by Mable Chan, Anders Leung, Bryan D. Griffin, Robert Vendramelli, Nikesh Tailor, Kevin Tierney, Jonathan Audet, Darwyn Kobasa

Subjects: “…ebola virus…”
Get full text

Vesicular Stomatitis Virus–Based Vaccines against Lassa and Ebola Viruses by Andrea Marzi, Friederike Feldmann, Thomas W. Geisbert, Heinz Feldmann, David Safronetz

“…We demonstrated that previous vaccination with a vesicular stomatitis virus (VSV)–based Lassa virus vaccine does not alter protective efficacy of subsequent vaccination with a VSV-based Ebola virus vaccine. These findings demonstrate the utility of VSV-based vaccines against divergent viral pathogens, even when preexisting immunity to the vaccine vector is present.…”
Get full text